The Allahabad High Court has dismissed Patanjali Ayurved Limited's petition challenging Rs 273.50-crore goods and service tax (GST) penalty. A division bench comprising Justices Shekhar B Saraf and Justice Vipin Chandra Dixit rejected Patanjali's argument that such penalties constitute criminal liability and can be imposed only after a criminal trial. The bench was of the view that tax authorities can impose penalties under Section 122 of the GST Act through civil proceedings without requiring criminal court trials. The court clarified that GST penalty proceedings are civil in nature and can be adjudicated by proper officers. "After detailed analysis, it is clear that the proceeding under Section 122 of the CGST Act is to be adjudicated by the adjudicating officer and is not required to undergo prosecution," the bench said. Patanjali Ayurved operates three manufacturing units at Haridwar (Uttarakhand), Sonipat (Haryana) and Ahmednagar (Maharashtra). The company came under ...
The Ministry of Corporate Affairs has sent a notice to Patanjali Ayurved over alleged fund diversion and governance lapses flagged by federal economic intelligence agencies
Yoga guru Ramdev on Friday gave an undertaking in the Delhi High Court for neither issuing any disparaging statement nor publishing on social media, posts similar to his "sharbat jihad" remark against Hamdard's Rooh Afza. Justice Amit Bansal, who on May 1 ordered removal of the controversial online content, asked Ramdev's counsel to file an affidavit during the day. A similar undertaking was also tendered by Ramdev's Patanjali Foods Ltd. The court passed the order while dealing with a lawsuit by Hamdard National Foundation India against Ramdev and his Patanjali Foods Ltd over the controversial remarks. Hamdard claimed while promoting Patanjali's "gulab sharbat", Ramdev alleged the money earned from Hamdard's Rooh Afza was used to build madrasas and mosques. On April 22, the court sought an affidavit from Ramdev and Patanjali that they shall "not issue any statements, social media posts or disparaging videos/advertisements in future similar to those which are subject matter of the
Ramdev ran alongside a horse to promote Patanjali's Shilajit, but when biotech millionaire Bryan Johnson questioned its anti-aging claims, he got blocked on X (formerly Twitter)
Revenue from Patanjali's edible oils segment, which makes up nearly three-fourths of its total revenue, rose 22.5% during the quarter
The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'
Baba Ramdev-led Patanjali Ayurved's total income has risen by 23.15 per cent to Rs 9,335.32 crore in 2023-24, helped by other income which includes OFS of Patanjali Foods (earlier known as Ruchi Soya) and income from other group entities, according to RoC filing by the company. In FY24 Patanjali Ayurved's other income was at Rs 2,875.29 crore against Rs 46.18 crore in the year-ago period, according to financial data accessed through business intelligence platform Tofler. Its revenue from operations, which is mainly income from net sales, was down 14.25 per cent to Rs 6,460.03 crore for the financial year ended on March 31, 2024. Revenue was impacted as Patanjali Ayurved transferred its food business to Patanjali Foods on July 1, 2022, which includes biscuits, ghee, cereals, and nutraceuticals. It reported a five-fold jump in its total profit to Rs 2,901.10 crore in FY24. Patanjali Ayurved reported a total profit of Rs 578.44 crore on a revenue of Rs 7,533.88 crore for the financi
Ramdev's fresh statement followed two days after the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders for misleading the public through ill-informed advertisements
Patanjali misleading ads case: The lawsuit accused yoga guru Ramdev of undermining public trust in allopathic treatments and promoting misinformation during the Covid-19 pandemic
The Delhi High Court instructed Ramdev to remove the contentious content from social media within three days
The Delhi High Court will on Monday pronounce its order on a plea by several doctors' associations against Yoga guru Ramdev over his claim of 'Coronil' being a "cure" for COVID-19. The plea forms a part of a 2021 lawsuit by the doctors' associations against the Ramdev, his associate Acharya Balkrishna as well as Patanjali Ayurveda. Justice Anup Jairam Bhambhani had reserved the order on the issue on May 21 after hearing the parties. According to the lawsuit, Ramdev made "unsubstantiated claims" with respect to 'Coronil' being a cure for COVID-19, contrary to the licence granted to the drug for merely being an "immuno-booster". The senior counsel appearing for the doctors had sought a direction to restrain the defendants, Ramdev and others, from making further similar statements. Three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneswar as well as Association of Resident Doctors, Post Graduate Institute of Medical Educati
The court had initially restrained Patanjali from selling its camphor products on August 30, 2023
The Bombay High Court has directed Patanjali Ayurved to deposit Rs 50 lakh for alleged breach of the HC's interim order restraining it from selling its camphor products, in relation to a trademark infringement case filed by another company. Following trademark infringement allegations by Mangalam Organics Ltd, the HC in an interim order in August 2023 restrained Patanjali Ayurved Ltd from selling its camphor products. A single bench of Justice R I Chagla on July 8 noted that Patanjali, in an affidavit submitted in June, admitted breach of the earlier order granting injunction against sale of the impugned camphor products. "Such persistent breach of the injunction order dated 30th August 2023 by defendant no. 1 (Patanjali) cannot be tolerated by this court," Justice Chagla said in the order, a copy of which was made available on Wednesday. The bench said it would be appropriate to direct Patanjali to deposit a sum of Rs 50 lakh prior to passing of an order for contempt/breach of the
Patanjali tells Supreme Court it has stopped selling 14 products whose manufacturing licences were suspended in Uttarakhand
A case in this regard was registered in 2021 after reports found the samples did not meet the food safety standards
The District Food Safety Officer of Pithoragarh collected the 'soan papdi' from a shop in Berinag Market in September 2019 following concerns about the Patanjali product
The court is hearing a petition filed by the Indian Medical Association (IMA) against Patanjali's advertisements attacking allopathy and making claims about curing certain diseases
Indian Medical Association (IMA) president R V Asokan on Tuesday tendered an unconditional apology to the Supreme Court and expressed regret for his statement against the apex court in an interview to PTI where he answered queries about Patanjali Ayurved Ltd's misleading advertisements case. The matter came up for hearing before a bench of justices Hima Kohli and Ahsanuddin Amanullah which posed some tough questions to Asokan and made it clear that at this stage, the apex court will not accept his affidavit tendering unconditional apology. In an affidavit filed in the top court, Asokan said he has realised his error that he ought not have made such statements in the interview when the matter was under consideration of the court. "The deponent (Asokan) hereby tenders his unconditional apology and expresses regret for his statements in relation to the order dated April 23, 2024 passed by this court in the present writ petition," the affidavit said. In its April 23 order, the apex cou
IMA President Dr RV Asokan drew sharp criticism from the Supreme Court for his remarks concerning the court's ruling in a case involving misleading advertisements by Patanjali Ayurved
Balkrishna and Patanjali Ayurved also served notice in Patanjali misleading ads case